Evidence map›Paper›PMID 35999889›Full record

ReviewJournal of radiology nursing2022

Axillary Lymphadenopathy Associated With COVID-19 Vaccination: Updates and Recommendations.

Sandra L Schwaner

Open access · greenAbstract readReview
In one paragraph

Review in Journal of radiology nursing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Sandra L SchwanerRetired from University of Virginia Health System, Charlottesville, Virginia.
University of Virginia Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphadenopathy (LAD) associated with vaccination has been documented as complicating the evaluation of metastatic malignancy. In the past this was a limited finding, primarily documented in association with smallpox and H1N1 vaccination.The advent of the novel mRNA vaccine for COVID-19 in December of 2021, and subsequent large scale vaccination effort, has resulted in a marked increase in the identification of LAD associated with vaccination. Because axillary LAD is a concerning sign of metastatic disease in breast cancer, identifying the difference between benign inflammatory reaction and concerning LAD and avoiding unnecessary additional imaging and biopsy is an essential skill. This article describes the current literature, recommendations for follow-up, and interventions to improve diagnostics.

Indexed as

BiopsyBreast cancerCoronavirusCOVID-19 vaccinationLymphadenopathyNursing carePatient educationReactive lymphadenopathyRecommendationsScreening mammogram

Identifiers

PMID35999889
PMCPMC9388443
OpenAlexW4292493924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.